Deschutes Portfolio Strategy »

Fulcrum Therapeutics shares owned by Deschutes Portfolio Strategy

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Deschutes Portfolio Strategy from 13F filings

Historical chart of Deschutes Portfolio Strategy investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Deschutes Portfolio Strategy consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Deschutes Portfolio Strategy

Quarter filed Position value Share count Share price at filing
2025-09-30 $171k 19k 9.20
2025-06-30 $180k 26k 6.88
2025-03-31 $279k 97k 2.88
2024-12-31 $604k 128k 4.70
2024-09-30 $381k 107k 3.57